adenovirus
adv
dna
virus
caus
diseas
variou
sever
upper
lower
respiratori
known
host
adv
respiratori
tract
infect
usual
mild
contrast
immunocompromis
host
acquir
immun
defici
syndrom
organ
transplant
recipi
adv
infect
often
interestingli
ever
sinc
fatal
case
adv
pneumonia
healthi
adult
report
sporad
case
sever
adv
pneumonia
patient
studi
describ
distinct
clinic
characterist
sever
adv
pneumonia
caus
particular
one
recent
studi
evalu
outcom
five
sever
adv
pneumonia
case
caus
patient
die
highlight
need
focu
emerg
highli
virul
adv
pathogen
even
present
approv
agent
proven
benefici
patient
adv
pneumonia
limit
data
respons
one
concern
issu
physician
face
regard
manag
adv
pneumonia
difficulti
predict
progress
respiratori
failur
rf
time
diagnosi
could
help
determin
appropri
medic
intervent
may
improv
overal
clinic
outcom
howev
data
regard
predict
factor
rf
patient
adv
pneumonia
therefor
present
studi
evalu
clinic
characterist
adv
pneumonia
patient
compar
pneumonia
patient
categor
adv
pneumonia
patient
accord
whether
rf
hospit
attempt
identifi
risk
factor
predict
rf
adv
pneumonia
patient
retrospect
review
medic
record
consecut
adult
patient
admit
pneumonia
june
may
arm
forc
capit
hospit
south
korea
hospit
largest
militari
referr
centr
soldier
treat
initi
militari
hospit
base
uniqu
characterist
korean
medic
system
data
rel
high
number
patient
collect
singl
centr
approxim
pneumonia
patient
militari
train
facil
patient
determin
human
immunodefici
viru
infect
test
patient
undergo
respiratori
viru
polymeras
chain
reaction
pcr
test
exclud
consequ
patient
neg
pcr
result
adv
pneumonia
patient
posit
pcr
result
adv
adv
pneumonia
includ
analysi
fig
diagnosi
adv
pneumonia
confirm
follow
find
present
acut
lower
respiratori
symptom
ii
lung
infiltr
chest
radiographi
comput
tomographi
ct
iii
evid
adv
infect
identifi
respiratori
viru
pcr
test
lower
respiratori
tract
sampl
sputum
bronchoalveolar
lavag
sampl
obtain
lower
respiratori
tract
consid
inadequ
sampl
upper
respiratori
tract
includ
oropharyng
nasopharyng
swab
obtain
institut
review
board
arm
forc
capit
hospit
arm
forc
medic
command
approv
studi
permit
review
public
patient
record
requir
inform
consent
individu
patient
waiv
given
retrospect
natur
studi
sever
adv
pneumonia
diagnos
sever
korean
militari
personnel
decemb
june
physician
referr
militari
hospit
endeavour
identifi
caus
respiratori
viral
agent
use
pcr
test
addit
common
bacteri
agent
thu
patient
present
acut
respiratori
symptom
deterior
despit
antibiot
therapi
day
andor
unusu
haematolog
find
includ
leukopenia
thrombocytopenia
suspect
atyp
caus
agent
underw
aetiolog
investig
infecti
aetiolog
evalu
peripher
blood
sputum
oropharyng
nasopharyng
secret
bronchoalveolar
lavag
fluid
use
techniqu
microbiolog
cultur
bacteria
mycobacterium
tuberculosi
multiplex
pcr
test
bacteri
agent
includ
streptococcu
pneumonia
haemophilu
influenza
mycoplasma
pneumonia
multiplex
pcr
test
respiratori
virus
base
previou
studi
outcom
administ
cidofovir
patient
adv
antivir
therapi
cidofovir
initi
patient
patient
adv
pneumonia
categor
three
group
accord
occurr
rf
fig
patient
rf
hospit
group
ii
patient
initi
rf
admiss
progress
rf
hospit
progress
rf
group
iii
patient
rf
admiss
initi
rf
group
rf
defin
partial
pressur
arteri
oxygenfract
inspir
oxygen
ratio
without
tachypnea
respir
rate
breath
per
minut
patient
oxygen
satur
without
oxygen
requir
hospit
undergo
arteri
blood
ga
analysi
consid
group
collect
data
clinic
outcom
analys
multiplex
pcr
perform
screen
common
respiratori
viru
pathogen
includ
adv
rhinoviru
influenza
viru
ab
respiratori
syncyti
viru
ab
bocaviru
coronaviru
parainfluenza
viru
metaneumoviru
use
rv
detect
kit
biosewoom
seoul
korea
roch
light
cycler
ii
instrument
roch
diagnost
mannheim
germani
accord
manufactur
instruct
serotyp
sampl
investig
sequenc
partial
hexon
genom
data
present
median
interquartil
rang
continu
variabl
number
percentag
categor
variabl
data
compar
use
test
continu
variabl
fisher
exact
test
categor
variabl
assess
predict
factor
occurr
rf
adv
pneumonia
univari
multivari
analys
backward
logist
regress
model
perform
use
variabl
univari
analysi
correct
use
bonferroni
method
counteract
problem
multipl
comparison
consid
indic
statist
signific
statist
analys
perform
use
pasw
softwar
program
ver
spss
inc
chicago
il
usa
total
patient
pneumonia
identifi
patient
undergo
respiratori
viru
pcr
test
exclud
patient
pneumonia
patient
adv
pneumonia
identifi
fig
adv
pneumonia
patient
mild
pneumonia
without
rf
hospit
rf
admiss
progress
rf
hospit
rf
admiss
evalu
clinic
characterist
adv
pneumonia
patient
compar
pneumonia
patient
tabl
patient
previous
healthi
men
median
age
year
patient
present
clinic
symptom
pneumonia
adv
pneumonia
patient
significantli
higher
rate
sore
throat
p
dyspnea
p
diarrhoea
p
versu
pneumonia
patient
white
blood
cell
count
p
platelet
count
p
adv
pneumonia
patient
significantli
lower
pneumonia
patient
overal
adv
pneumonia
patient
progress
rf
hospit
greater
incid
pneumonia
patient
group
p
shown
tabl
respiratori
virus
adv
identifi
adv
patient
group
rhinoviru
influenza
respiratori
syncyti
viru
enteroviru
bacteri
aetiolog
commonli
identifi
pneumonia
group
p
pneumonia
haemophilu
influenza
frequent
isol
pathogen
among
adv
pneumonia
patient
bacteri
infect
pneumonia
h
influenza
pneumonia
patient
receiv
initi
empir
antibiot
includ
ceftriaxon
azithromycin
n
moxifloxacin
n
levofloxacin
n
amoxicillin
clavulan
n
piperacillintazobactam
n
cidofovir
appli
adv
pneumonia
patient
seven
patient
initi
rf
patient
progress
rf
rf
compar
find
among
adv
pneumonia
patient
categor
three
group
consist
progress
rf
initi
rf
group
tabl
age
bodi
mass
index
smoke
statu
clinic
symptom
sign
differ
among
adv
patient
group
except
lower
rate
initi
dyspnea
group
p
regard
initi
laboratori
find
interestingli
monocyt
percentag
absolut
monocyt
count
rf
patient
significantli
lower
patient
p
howev
differ
monocyt
percentag
absolut
monocyt
count
patient
progress
rf
initi
rf
signific
figur
supplementari
inform
addit
monocytopenia
common
rf
patient
patient
p
commonli
isol
adv
serotyp
human
bacteri
differ
among
patient
group
patient
adv
pneumonia
rf
six
requir
mechan
ventil
one
requir
extracorpor
membran
oxygen
support
one
die
rf
massiv
hemorrhag
infarct
adv
pneumonia
patient
initi
chest
ct
imag
avail
patient
tabl
patient
progress
rf
initi
rf
show
predominantli
consolid
ground
glass
opac
fig
b
lobar
distribut
patient
predominantli
consolid
ground
glass
opac
fig
approxim
half
lobar
distribut
bilater
involv
p
multilobar
infiltr
lobe
p
pleural
effus
p
significantli
common
rf
patient
assess
predict
factor
occurr
rf
univari
multivari
analys
logist
regress
model
perform
among
patient
rf
patient
progress
rf
hospit
tabl
univari
analysi
monocytopenia
p
multilobar
infiltr
p
pleural
effus
p
significantli
associ
rf
howev
multivari
analysi
monocytopenia
remain
signific
p
predict
rf
present
studi
describ
characterist
adv
pneumonia
adult
patient
evalu
predict
factor
occurr
rf
import
find
initi
monocytopenia
may
help
predict
rf
cours
diseas
adv
pneumonia
patient
moreov
given
paramet
routin
investig
admiss
partial
pressur
arteri
oxygen
oxygen
satur
serum
protein
level
reflect
present
condit
predict
risk
rf
time
diagnosi
adv
pneumonia
may
help
stratifi
medic
intervent
determin
whether
start
earli
antivir
date
accur
data
modal
could
help
predict
clinic
deterior
patient
adv
pneumonia
regard
abnorm
haematolog
find
associ
sever
adv
infect
chen
et
al
recent
indic
patient
pneumonia
upper
respiratori
infect
asymptomat
infect
higher
neutrophil
percentag
lower
lymphocyt
percentag
lower
platelet
count
compar
healthi
howev
report
patient
rel
sever
infect
pneumonia
upper
respiratori
infect
tend
higher
monocyt
percentag
asymptomat
infect
healthi
control
acut
phase
infect
partial
contradict
studi
regard
monocyt
percentag
adv
infect
could
explain
fact
includ
pneumonia
patient
compar
characterist
accord
presenc
rf
reflect
diseas
progress
patient
mild
pneumonia
without
rf
similar
aforement
studi
half
n
elev
monocyt
percentag
differenti
cell
count
one
patient
monocytopenia
adenoviru
infect
initi
lead
neutrophil
interstiti
inflamm
alveol
subsequ
monocyt
infiltr
lung
later
stage
ill
neutrophilicmonocyt
inflamm
may
convert
lymphocyt
regard
inflammatori
process
wenxin
et
al
recent
demonstr
adv
infect
initi
induc
cytokin
mediat
neutrophil
recruit
subsequ
chemokin
macrophag
inflammatori
protein
may
contribut
monocyt
infiltr
diseas
sever
studi
addit
indic
sever
adv
infect
associ
mark
imbal
inflammatori
cell
cytokin
respons
includ
tumour
base
data
result
impli
adv
pneumonia
becom
sever
inflammatori
process
includ
monocyt
chemotaxi
inflammatori
cell
product
becom
uncontrol
aberr
may
contribut
abnorm
haematolog
find
context
result
highlight
import
clinic
implic
abnorm
find
peripher
blood
especi
progress
monocytopenia
treat
patient
adv
pneumonia
evalu
sever
pneumonia
radiolog
find
multilobar
infiltr
pleural
effus
gener
indic
greater
sever
radiolog
paramet
alon
may
accur
predict
prognosi
without
serial
expect
studi
domin
pattern
distribut
ct
imag
discrimin
patient
rf
moreov
although
sever
paramet
indic
increas
sever
multilobar
pleural
effus
tend
frequent
observ
rf
patient
statist
signific
multivari
analysi
predict
rf
adv
pneumonia
interestingli
studi
isol
type
similar
previou
studi
report
seven
case
sever
adv
one
previou
studi
evalu
serotyp
among
korean
militari
recruit
show
type
common
isol
patient
includ
mild
acut
respiratori
one
studi
evalu
case
adv
patient
sever
diseas
compar
infect
serotyp
thu
could
emerg
major
pathogen
howev
limit
data
exist
surveil
need
present
studi
sever
limit
first
studi
conduct
militari
hospit
popul
repres
gener
popul
term
age
gender
live
condit
mode
infect
second
studi
retrospect
possibl
effect
bacteri
viral
clinic
cours
pneumonia
exclud
third
common
adv
serotyp
studi
patient
inflammatori
respons
differ
adv
serotyp
evalu
conclus
data
suggest
initi
monocytopenia
may
help
predict
rf
cours
adv
pneumonia
adult
patient
